These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35743443)

  • 1. How to Optimize Cardioversion of Atrial Fibrillation.
    Airaksinen KEJ
    J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early versus delayed cardioversion: why should we wait?
    Airaksinen KEJ
    Expert Rev Cardiovasc Ther; 2020 Mar; 18(3):149-154. PubMed ID: 32164464
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardioversion for atrial fibrillation - how to prevent thromboembolic complications?
    Jaakkola S; Kiviniemi TO; Airaksinen KEJ
    Ann Med; 2018 Nov; 50(7):549-555. PubMed ID: 30207497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal timing for cardioversion in patients with atrial fibrillation.
    Hellman T; Kiviniemi T; Nuotio I; Biancari F; Vasankari T; Hartikainen J; Lehto M; Airaksinen KE;
    Clin Cardiol; 2018 Jul; 41(7):966-971. PubMed ID: 29802625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Atrial fibrillation: always cardioversion? No].
    Di Pasquale G; Biancoli S; Sassone B; Pancaldi LG
    Ital Heart J Suppl; 2002 Jan; 3(1):81-90. PubMed ID: 11899578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of cardioversion in atrial fibrillation: the sooner the better?
    Capranzano P; Calvi V
    Eur Heart J Suppl; 2020 Nov; 22(Suppl L):L41-L43. PubMed ID: 33654465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study.
    Crijns HJ; Weijs B; Fairley AM; Lewalter T; Maggioni AP; Martín A; Ponikowski P; Rosenqvist M; Sanders P; Scanavacca M; Bash LD; Chazelle F; Bernhardt A; Gitt AK; Lip GY; Le Heuzey JY
    Int J Cardiol; 2014 Apr; 172(3):588-94. PubMed ID: 24556445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transesophageal echocardiography in patients with atrial fibrillation, candidates for cardioversion: usefulness and limitations].
    Antonielli E; Pizzuti A; Gandolfo N; Bosco M; Sclavo M; Magnacca M; Leonardi G; Doronzo B; Baralis G; Di Leo M
    G Ital Cardiol; 1995 May; 25(5):543-52. PubMed ID: 7642059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological cardioversion of atrial fibrillation: current management and treatment options.
    Boriani G; Diemberger I; Biffi M; Martignani C; Branzi A
    Drugs; 2004; 64(24):2741-62. PubMed ID: 15563247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Singer DE; Albers GW; Dalen JE; Fang MC; Go AS; Halperin JL; Lip GYH; Manning WJ
    Chest; 2008 Jun; 133(6 Suppl):546S-592S. PubMed ID: 18574273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of left atrial stunning after cardioversion of recent-onset atrial fibrillation in patients at low-stroke risk.
    Antonielli E; Pizzuti A; Dogliani S; Stasi M; Bassignana A; Doronzo B
    Eur J Emerg Med; 2017 Jun; 24(3):217-223. PubMed ID: 26458205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of recurrence rates after direct-current cardioversion for new-onset atrial fibrillation in patients receiving versus those not receiving rhythm-control drug therapy.
    Li H; Riedel R; Oldemeyer JB; Rovang K; Hee T
    Am J Cardiol; 2004 Jan; 93(1):45-8. PubMed ID: 14697464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Types and outcomes of cardioversion in patients admitted to hospital for atrial fibrillation: results of the German RHYTHM-AF Study.
    Gitt AK; Smolka W; Michailov G; Bernhardt A; Pittrow D; Lewalter T
    Clin Res Cardiol; 2013 Oct; 102(10):713-23. PubMed ID: 23812041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of cardioversion in atrial fibrillation lasting less than 48 h without post-procedural anticoagulation in patients at low cardioembolic risk.
    Tampieri A; Cipriano V; Mucci F; Rusconi AM; Lenzi T; Cenni P
    Intern Emerg Med; 2018 Jan; 13(1):87-93. PubMed ID: 28025766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary approach to electrical and pharmacological cardioversion of atrial fibrillation.
    Rajagopalan B; Curtis AB
    Postgrad Med; 2012 Nov; 124(6):26-35. PubMed ID: 23322136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre- and post-cardioversion transesophageal echocardiography for brief anticoagulation therapy with enoxaparin in atrial fibrillation patients: a prospective study with a 1-year follow-up.
    de Luca I; Sorino M; De Luca L; Colonna P; Del Salvatore B; Corlianò L
    Int J Cardiol; 2005 Jul; 102(3):447-54. PubMed ID: 16004890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation.
    Van Gelder IC; Tuinenburg AE; Schoonderwoerd BS; Tieleman RG; Crijns HJ
    Am J Cardiol; 1999 Nov; 84(9A):147R-151R. PubMed ID: 10568674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of Thromboembolic Complications Within 30 Days of Electrical Cardioversion Performed Within 48 Hours of Atrial Fibrillation Onset.
    Garg A; Khunger M; Seicean S; Chung MK; Tchou PJ
    JACC Clin Electrophysiol; 2016 Aug; 2(4):487-494. PubMed ID: 29759870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role amiodarone in sinus rhythm maintenance after successful cardioversion in patients with chronic non-valvular atrial fibrillation].
    Kosior D; Szulc M; Zawadzka M; Pierścińska M; Stawicki S; Rabczenko D; Torbicki A; Opolski G
    Pol Arch Med Wewn; 2002 Dec; 108(6):1151-60. PubMed ID: 12687927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic treatment management in low stroke risk patients undergoing cardioversion of atrial fibrillation <48 h duration: results of an EHRA survey.
    Migliore F; Providencia R; Farkowski MM; Dan GA; Daniel S; Potpara TS; Jubele K; Chun JKR; de Asmundis C; Zorzi A; Boveda S
    Europace; 2021 Sep; 23(9):1502-1507. PubMed ID: 33990842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.